| Literature DB >> 35907916 |
Nehal Ibrahim1, Haidy Abbas2, Nesrine S El-Sayed3, Heba A Gad4,5.
Abstract
A shift towards natural anti-aging ingredients has spurred the research to valorize traditionally used plants. In this context, Rosmarinus officinalis L. was evaluated for its photoprotective, antioxidant, anti-inflammatory, and anti-wrinkling properties. GC/MS and LC-ESI-HRMS based phytochemical profiling of rosemary leaves hexane extract resulted in the identification of 47 and 31 compounds, respectively and revealed rich content in triterpenoids, monoterpenoids and phenolic diterpenes. In vitro assays confirmed the antioxidant, anti-aging, and wound healing potential of rosemary extract along with a good safety profile, encouraging further development. A systematic molecular modelling study was conducted to elucidate the mechanistic background of rosemary anti-aging properties through the inhibitory effects of its major constituents against key anti-aging targets viz. elastase, collagenase, and hyaluronidase. Development of rosemary extract lipid nanocapsules-based mucoadhesive gels was performed to improve skin contact, permeation, and bioavailability prior to in vivo testing. The developed formulae demonstrated small particle size (56.55-66.13 nm), homogenous distribution (PDI of 0.207-0.249), and negatively charged Zeta potential (- 13.4 to - 15.6). In UVB-irradiated rat model, topical rosemary hexane extract-loaded lipid nanocapsules-based gel provided photoprotection, restored the antioxidant biochemical state, improved epidermal and dermal histological features, and decreased the level of inflammatory and wrinkling markers. The use of rosemary hexane extract in anti-aging and photoprotective cosmeceuticals represents a safe, efficient, and cost-effective approach.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35907916 PMCID: PMC9338973 DOI: 10.1038/s41598-022-16592-7
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Compositional profile of R. officinalis hexane extract as analysed by GC-MS.
| No | RT (min) | RI expa | RI litb | Metabolitec | Relative percentile |
|---|---|---|---|---|---|
| 1 | 7.07 | 914 | 914 | 1.73 | |
| 2 | 7.52 | 929 | 929 | Camphene | 0.46 |
| 3 | 7.7 | 936 | 937 | 2,4(10)-Thujadiene | 0.1 |
| 4 | 8.39 | 960 | 960 | 0.13 | |
| 5 | 9.45 | 998 | 998 | 0.08 | |
| 6 | 9.93 | 1013 | 1013 | 0.07 | |
| 7 | 10.05 | 1017 | 1017 | Limonene | 0.4 |
| 8 | 10.11 | 1019 | 1019 | Eucalyptol | 1.63 |
| 9 | 12.34 | 1089 | 1089 | Linalool | 0.45 |
| 10 | 13.73 | 1133 | 1133 | Camphor | 2.07 |
| 11 | 14.32 | 1152 | 1152 | Pinocarvone | 0.12 |
| 12 | 14.42 | 1155 | 1155 | Borneol | 1.07 |
| 13 | 14.68 | 1163 | 1162 | Isopinocamphone | 0.17 |
| 14 | 15.22 | 1180 | 1180 | 0.21 | |
| 15 | 15.59 | 1192 | 1196 | Isoborneol | 0.09 |
| 16 | 15.77 | 1198 | 1198 | Verbenone | 2.08 |
| 17 | 16.78 | 1233 | 1234 | 0.21 | |
| 18 | 18.02 | 1276 | 1276 | Bornyl acetate | 0.31 |
| 19 | 21.8 | 1408 | 1408 | Caryophyllene | 0.2 |
| 20 | 42.19 | 2368 | 2300 | Tricosane | 0.21 |
| 21 | 43.84 | 2467 | 2400 | Tetracosane | 0.27 |
| 22 | 44.78 | 2528 | 2525 | Diisooctyl phthalate | 0.19 |
| 23 | 45.42 | 2569 | 2500 | Pentacosane | 0.43 |
| 24 | 46.93 | 2666 | 2600 | Hexacosane | 0.8 |
| 25 | 48.39 | 2760 | 2700 | Heptacosane | 0.65 |
| 26 | 49.83 | 2853 | 2800 | Octacosane | 3.07 |
| 27 | 51.18 | 2939 | 2865 | 2-methyloctacosane | 0.9 |
| 28 | 52 | 2992 | 2965 | 2-Methylnonacosane | 0.35 |
| 29 | 52.53 | 3026 | 3000 | Triacontane | 6.73 |
| 30 | 53.29 | 3075 | 3112 | 0.34 | |
| 31 | 53.49 | 3087 | 3015 | 3,7-dimethyl-nonacosane | 0.54 |
| 32 | 53.83 | 3110 | 3100 | Hentriacontane | 1.34 |
| 33 | 54.58 | 3157 | 3120 | n-Octacosanol | 0.21 |
| 34 | 54.73 | 3167 | 3100 | Hentriacontane | 1.26 |
| 35 | 55.36 | 3208 | 3200 | Dotriacontane | 16.21 |
| 36 | 56.34 | 3270 | 3225 | 16-Methyldotriacontane | 0.36 |
| 37 | 56.56 | 3285 | 3235 | 12-Methyldotriacontane | 1.7 |
| 38 | 56.69 | 3294 | 3337 | 10.4 | |
| 39 | 56.99 | 3313 | 3300 | Tritriacontane | 1.11 |
| 40 | 57.1 | 3319 | 3337 | 3.95 | |
| 41 | 57.57 | 3350 | 3376 | 20.64 | |
| 42 | 58 | 3377 | 3376 | 3.79 | |
| 43 | 58.19 | 3389 | 3338 | 15-Methyltritriacontane | 0.71 |
| 44 | 58.98 | 3440 | 3400 | Tetratriacontane | 5.11 |
| 45 | 59.35 | 3464 | 3384 | Lupenone | 0.67 |
| 46 | 62.4 | 3660 | 3525 | Lupeol acetate | 4.91 |
| 47 | 62.62 | 3674 | 3629 | Betulinaldehyde | 0.86 |
| % Total Identified | 99.29 | ||||
| % Monoterpenes | 2.97 | ||||
| % Oxygenated monoterpenes | 8.41 | ||||
| % Sesquiterpenes | 0.2 | ||||
| % Hydrocarbons | 41.75 | ||||
| % Triterpenoids | 45.22 | ||||
| Others | 0.74 | ||||
aRetention index calculated experimentally on Rtx-5MS column relative to C8-C28 n-alkanes series.
bCorresponding Kovats retention index from literature and spectral databases.
cIdentification based on comparing retention indices (RI) and mass spectral data (MS) with those found in NIST Mass Spectral Library (2011), Wiley Registry of Mass Spectral Data (8th edition) and reported in literature.
Phytochemical composition of R. officinalis hexane extract as analysed by LC-ESI-HRMS in negative ion mode.
| No | RT (min) | Annotation | Molecular formula | Exp. [M-H]−
| Exact mass | MS/MS | Error (ppm) | Class | Refs. |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 19.234 | Coniferyl alcohol | C10H12O3 | 179.0712 | 180.0786 | nd | 0.49 | Phenylpropanoid | [ |
| 2 | 26.094 | Podolide | C19H22O5 | 329.1405 | 330.1467 | nd | − 4.28 | Norditerpene | [ |
| 3 | 29.12 | Rosmanol | C20H26O5 | 345.1717, 691.3501 [2 M-H]− | 346.178 | 283, 301 | − 1.76 | Phenolic diterpene | [ |
| 4 | 30.331 | (Epi)(iso)rosmanol I | C20H26O5 | 345.1718, 691.3507 [2 M-H]− | 346.178 | 283, 301 | − 3.09 | Phenolic diterpene | [ |
| 5 | 31.441 | (Epi)(iso)rosmanol II | C20H26O5 | 345.1719 | 346.178 | 283, 301 | − 3.14 | Phenolic diterpene | [ |
| 6 | 34.568 | Lariciresinol | C20H24O6 | 359.1509 | 360.1573 | nd | − 2.48 | lignan | [ |
| 7 | 35.072 | Unidentified | C19H22O4 | 313.1452 | 314.1518 | nd | − 2.15 | ||
| 8 | 36.485 | Rosmadial | C20H24O5 | 343.1563, 687.3191 [2 M-H]− | 344.1624 | 299, 315, 313 | − 3.34 | Phenolic diterpene | [ |
| 9 | 37.494 | (Epi)rosmanol methyl ether | C21H28O5 | 359.1877 | 360.1937 | 344, 315, 329 | − 3.36 | Phenolic diterpene | [ |
| 10 | 38.099 | Carnosol | C20H26O4 | 329.1772, 659.3604 [2 M-H]− | 330.1831 | 285 | − 3.95 | Phenolic diterpene | [ |
| 11 | 39.713 | Rosmadial isomer | C20H24O5 | 343.1565 | 344.1624 | 299, 315 | − 3.71 | Phenolic diterpene | [ |
| 12 | 40.621 | Unidentified | C19H34O4 | 325.2395 | 326.2457 | nd | − 2.94 | ||
| 13 | 40.722 | Rosmaridiphenol | C20H28O3 | 315.1977, 631.4020 [2 M-H]− | 316.2038 | 285, 135 | − 3.58 | Phenolic diterpene | [ |
| 14 | 40.823 | Carnosic acid | C20H28O4 | 331.1928, 663.3922 [2 M-H]− | 332.1988 | 244 | − 3.91 | Phenolic diterpene | [ |
| 15 | 40.924 | Rosmaridiphenol isomer I | C20H28O3 | 315.1980, 631.4024 [2 M-H]− | 316.2038 | nd | − 4.43 | Phenolic diterpene | [ |
| 16 | 41.025 | Rosmaridiphenol isomer II | C20H28O3 | 315.1977 | 316.2038 | nd | − 3.46 | Phenolic diterpene | [ |
| 17 | 42.03 | Unidentified | C23H32O3 | 355.2291 | 356.2351 | nd | − 3.21 | ||
| 18 | 42.74 | Carnosol isomer | C20H26O4 | 329.1770, 659.3601 [2 M-H]− | 330.1831 | nd | − 3.37 | Phenolic diterpene | [ |
| 19 | 43.648 | Asiatic acid | C30H48O5 | 487.3444, 975.6934 [2 M-H]− | 488.3502 | nd | − 2.95 | Triterpenoid | [ |
| 20 | 45.06 | 12-O-methylcarnosic acid | C21H30O4 | 345.2080 | 346.2144 | 301 | − 2.85 | Phenolic diterpene | [ |
| 21 | 45.665 | Carnosic acid isomer | C20H28O4 | 331.1916 | 332.1988 | nd | − 0.38 | Phenolic diterpene | [ |
| 22 | 47.3 | Asiatic acid isomer | C30H48O5 | 487.3438 | 488.3502 | nd | − 2.29 | Triterpenoid | |
| 23 | 47.683 | betulinic acid | C30H48O3 | 455.3543 | 456.3603 | 455, 411 | − 2.7 | Triterpenoid | [ |
| 24 | 48.288 | Lanopalmitic acid | C16H32O3 | 271.2283 | 272.2351 | nd | − 1.54 | Hydroxy fatty acid | [ |
| 25 | 48.49 | Unidentified triterpenoid | C30H46O3 | 453.3378 | 454.3447 | nd | − 0.73 | Triterpenoid | |
| 26 | 48.995 | Oleanolic acid | C30H48O3 | 455.3537 | 456.3603 | 407 | − 1.25 | Triterpenoid | [ |
| 27 | 50.810 | Ursolic acid | C30H48O3 | 455.3540 | 456.3603 | nd | − 1.26 | Triterpenoid | [ |
| 28 | 51.618 | Unidentified triterpenoid | C30H44O3 | 451.3230, 903.6532 [2 M-H]− | 452.329 | nd | − 3.07 | Triterpenoid | |
| 29 | 52.626 | Unidentified triterpenoid | C30H46O3 | 453.3390, 907.6833 [2 M-H]− | 454.3447 | nd | − 2.84 | Triterpenoid | |
| 30 | 59.89 | Augustic acid | C30H48O4 | 471.3498 | 472.3553 | nd | − 2.79 | Triterpenoid | [ |
| 31 | 72.298 | Pyro-pheophytin-b | C53H70N4O4 | 825.5338 | 826.5397 | nd | − 7.15 | Chlorophyll derivative | [ |
Antioxidant activity of R. officinalis hexane extract.
| Sample | DPPH (IC50, µg/mL) | ABTS (mM TE/g extract) | FRAP (mM TE/g extract) |
|---|---|---|---|
| RHE | 221.6 ± 11.8 | 310.54 ± 12.32 | 394.69 ± 17.28 |
| Trolox | 6.11 ± 0.2 | – | – |
In-vitro antiaging potential of R. officinalis hexane extract.
| Sample | IC50 (µg/mL) | ||
|---|---|---|---|
| Elastase | Collagenase | Hyaluronidase | |
| RHE | 57.61 ± 2.93 | 520.2 ± 26.5 | 448.1 ± 22.8 |
| 1,10-Phenanthroline | 25.6 ± 1.3 | 340.8 ± 17.3 | 234.6 ± 11.9 |
Docking scores of RHE major constituents against elastase, hyaluronidase and collagenase as compared to the control, 1,10-phenanthroline.
| Compound | Compound structure | Glide G-score | |||
|---|---|---|---|---|---|
| Elastase | Collagenase | Hyaluronidase | |||
| Verbenone |
| − 5.327 | − 5.281 | − 3.829 | |
| α-Amyrin |
| − 4.563 | − 3.508 | − 3.398 | |
| Camphor |
| − 4.273 | − 5.402 | − 4.515 | |
| β-Amyrin |
| − 3.515 | − 3.765 | − 3.339 | |
| Lupeol acetate |
| − 3.267 | − 3.465 | − 2.072 | |
| Octacosane |
| − 2.424 | − 3.903 | − 0.698 | |
| Triacontane* |
| * | − 2.95 | − 0.885 | |
| Doctriacontane* |
| * | − 4.767 | − 0.775 | |
| Tetratriacontane* |
| * | * | * | |
| 1,10-Phenanthroline |
| − 4.556 | − 6.931 | − 4.714 | |
*Compounds were rejected by the docking engine due to their exceedingly large size.
Figure 13D docking pose and 2D interaction diagram of verbenone in the binding site of elastase (A,B), collagenase (C,D) (showing lack of metal coordination interaction) and hyaluronidase (E,F) (showing excessive water exposure).
Figure 23D docking pose and 2D interaction diagram of camphor in the binding site of collagenase (A,B) and hyaluronidase (C,D).
Composition and characterization of blank and rosemary-loaded lipid nanocapsules (RM-LNC).
| Formula | Particle size | PDI ± S.D | Zeta potential |
|---|---|---|---|
| Blank LNC | 42.28 ± 0.417 | 0.048 ± 0.001 | − 12.6 ± 1.41 |
| Blank LNC gel | 45.72 ± 0.079 | 0.032 ± 0.004 | − 11.2 ± 0.70 |
| 4% RM-LNC | 55.20 ± 0.218 | 0.175 ± 0.016 | − 13.1 ± 0.63 |
| 4% RM-LNC gel | 56.55 ± 0.384 | 0.207 ± 0.014 | − 13.4 ± 0.91 |
| 10% RM-LNC | 64.81 ± 1.113 | 0.262 ± 0.028 | − 15.4 ± 2.62 |
| 10% RM-LNC gel | 66.13 ± 1.306 | 0.249 ± 0.007 | − 15.6 ± 0.89 |
PDI: polydispersity index, S.D.: standard deviation.
Effect of UVB-irradiation and different formulations on the oxidative stress, inflammatory and wrinkling markers in rats.
| Group | Antioxidant parameters | Anti-inflammatory parameters | Anti-wrinkling parameters | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Catalase | SOD | GSH | IL—6 | IL—1 beta | NF—KB | GM—CSF | MMP1 | Elastase | Neprilysin | |
| U/g tissue | U/g tissue | Pg/g tissue | Pg/g tissue | Pg/g tissue | ng/g tissue | Pg/g tissue | ng/g tissue | ng/g tissue | Pg/g issue | |
| NC | 38.7 ± 1.14 | 45.6 ± 1.29 | 50.6 ± 1.10 | 14.1 ± 1.18 | 20.4 ± 1.2 | 23.4 ± 1.19 | 6.4 ± 0.87 | 2.1 ± 0.68 | 1.6 ± 0.85 | 26.7 ± 1.68 |
| PC | 7.8 ± 0.95* | 12.3 ± 1.54* | 17.4 ± 1.13* | 40.1 ± 1.85* | 46.1 ± 0.84* | 55.2 ± 0.75* | 29.1 ± 1.25* | 9.5 ± 1.06* | 7.9 ± 1.05* | 51.2 ± 1.15* |
| T1 | 14.3 ± 0.92*@ | 19.7 ± 0.65*@ | 24.5 ± 1.22*@ | 27.6 ± 1.65*@ | 19.1 ± 1.35*@ | 36.5 ± 1.16*@ | 19.1 ± 1.35*@ | 6.7 ± 0.85*@ | 5.6 ± 0.79*@ | 40.1 ± 1.12*@ |
| T2 | 29.5 ± 1.35*@# | 24.8 ± 0.98*@# | 29.5 ± 1.35*@# | 23.4 ± 1.42*@# | 29.7 ± 1.3*@# | 32.4 ± 1.18*@# | 15.7 ± 1.2*@# | 5.4 ± 0.98*@# | 4.6 ± 1.02*@# | 35.2 ± 1.4*@# |
| T3 | 38.2 ± 1.64*@#a | 32.9 ± 0.88*@# a | 38.2 ± 1.64*@# a | 16.9 ± 1.85*@# a | 23.1 ± 1.06*@# a | 25.4 ± 1.06*@# a | 9.2 ± 1.05*@# a | 3.2 ± 0.56*@# a | 2.3 ± 0.65*@# a | 28.9 ± 1.8*@# a |
| T4 | 12.3 ± 0.65*@#+++ | 15.8 ± 1.05*@#+++ | 20.4 ± 1.16*@#+++ | 32.1 ± 1.88*@#+++ | 23.7 ± 1.23*@#+++ | 40.3 ± 1.06*@#+++ | 23.7 ± 1.23*@#+++ | 7.7 ± 0.62*@#+++ | 6.4 ± 0.56*@#+++ | 44.6 ± 1.65*@#+++ |
NC: Negative control (normal rats), PC: positive control (subjected to UVB irradiation and received no treatment), while T1, T2, T3 and T4 received RHE, 4%-RM-LNC gel, 10% RM-LNC gel and plain LNC gel. Each value is presented as mean ± standard error of the mean (SE) for 10 rats.
*Statistically significantly different from the normal control group (P < 0.05).
@Statistically significantly different from the positive control group (P < 0.05).
#Statistically significantly different from the T1 group (P < 0.05).
aStatistically significantly different from the T2 group (P < 0.05).
+++Statistically significantly different from the T3 group (P < 0.05).
Cutaneous irritancy test.
| Rat | Negative control | Positive control | T1 | T2 | T3 | T4 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Er | Ed | Er | Ed | Er | Ed | Er | Ed | Er | Ed | Er | Ed | |
| 1 | 1 | 0 | 4 | 3 | 1 | 0 | 1 | 0 | 2 | 0 | 1 | 0 |
| 2 | 0 | 0 | 3 | 4 | 1 | 0 | 1 | 0 | 1 | 1 | 2 | 1 |
| 3 | 0 | 0 | 4 | 4 | 1 | 0 | 0 | 0 | 2 | 1 | 2 | 1 |
| 4 | 1 | 0 | 4 | 3 | 2 | 1 | 0 | 1 | 2 | 0 | 2 | 1 |
| 5 | 1 | 0 | 4 | 4 | 2 | 1 | 1 | 0 | 1 | 1 | 2 | 1 |
| 6 | 1 | 0 | 4 | 4 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 |
| Average | 0.66 | 0 | 3.83 | 3.66 | 1.33 | 0.5 | 0.66 | 0.166 | 1.5 | 0.66 | 1.66 | 0.66 |
| PII | 0.66 | ± 0.15 | 7.5+++ | ± 0.16 | 1.83†a | ± 0.12 | 0.83†a | ± 0.13 | 2.16†a | ± 0.14 | 2.33†a | ± 0.16 |
+++Significant (p < 0.001) when compared to group 1.
aSignificant (p < 0.001) when compared to group 2.
†Non-significant (p > 0.05) when compared to group 1.
Figure 3Histopathological examination of rat dorsal skin. Negative control: normal rats, positive control: subjected to UVB irradiation and received no treatment, while T1, T2, T3 and T4 received RHE, 4%-RM-LNC gel, 10% RM-LNC gel and plain LNC gel.
Evaluation of skin reactions.
| Skin reaction | Score |
|---|---|
| None | 0 |
| Very slight erythema | 1 |
| Well defined erythema | 2 |
| Moderate to severe erythema | 3 |
| Severe erythema and scar formation | 4 |
| None | 0 |
| Very slight edema | 1 |
| Slight edema (edges of area well defined by definite raising) | 2 |
| Moderate edema (area raised approximately 1 mm.) | 3 |
| Severe edema (raised more than 1 mm. and extending beyond area of exposure | 4 |